Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. - Test2 - elhamkhani - TriplyDB

Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis.

Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis.

http://www.wikidata.org/entity/Q35338937

about

Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials The microbial-mammalian metabolic axis: a critical symbiotic relationship Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis Flavin-Containing Monooxygenase 3 Reduces Endoplasmic Reticulum Stress in Lipid-Treated Hepatocytes Microbial-Host Co-metabolites Are Prodromal Markers Predicting Phenotypic Heterogeneity in Behavior, Obesity, and Impaired Glucose Tolerance Genetic Variation in Choline-Metabolizing Enzymes Alters Choline Metabolism in Young Women Consuming Choline Intakes Meeting Current Recommendations.Role of Insulin in the Regulation of Proprotein Convertase Subtilisin/Kexin Type 9.Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk Diets high in resistant starch increase plasma levels of trimethylamine-N-oxide, a gut microbiome metabolite associated with CVD risk.Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosis Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.Insulin Dissociates the Effects of Liver X Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and Inflammation.Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans.Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors.Circulating MiRNA biomarkers serve as a fingerprint for diabetic atherosclerosis Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.Genetic Variant in Flavin-Containing Monooxygenase 3 Alters Lipid Metabolism in Laying Hens in a Diet-Specific Manner.Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease Diet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk.miRNA and cholesterol homeostasis.The complex metabolism of trimethylamine in humans: endogenous and exogenous sources.Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease.Microbiome, trimethylamine N-oxide, and cardiometabolic disease.Emerging roles of xenobiotic detoxification enzymes in metabolic diseases.Regulated methionine oxidation by monooxygenases.Canonical microRNAs Enable Differentiation, Protect Against DNA Damage, and Promote Cholesterol Biosynthesis in Neural Stem Cells.Flavin-containing monooxygenases in aging and disease: Emerging roles for ancient enzymes.EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice.Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD.Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue.Inactivation mechanism of N61S mutant of human FMO3 towards trimethylamine.Changes in Gut Microbiota-Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial.Fructose and glucose regulate mammalian target of rapamycin complex 1 and can activate lipogenic gene expression via distinct pathways.

P2860

Q26823198-7D27CF49-E497-46A2-8915-E89362C1BC88 Q28077742-35303633-C0BD-4FC7-A6D4-7FA4657C697F Q28828859-41A8CFA4-36A9-423C-9654-27D213F7DA6A Q29038812-50F4E0AF-AC3B-47BC-96EE-9820415847C4 Q33631394-6FD99E58-2F66-42B4-8379-EFCA4707AE92 Q33899037-1A1645B9-6E12-41CB-8E9A-0720348B38D3 Q34680631-046AB0D6-F6F3-4668-BBEC-83BD54D5AD47 Q35794774-D29054B0-6C4A-44C8-9471-0A9F82BA997D Q35955435-0CD65553-8C8E-47B8-BC02-20C3A3860D95 Q36228851-EA83EB51-C62F-4D28-8D25-D779A995A81F Q36337990-C046F535-65D0-4A05-B17E-D3E61249104E Q36340545-94F37F0E-8647-4DA4-BAAE-0B2C877711A5 Q36466124-929CA03B-A245-459D-BC13-FBFF46E9A89D Q36827878-3CB54092-4BB0-49FF-9251-C1653F17C53F Q36941666-6C07181E-36A6-4BBE-A24F-0836984ADA0D Q36968992-30332B5C-D699-46D0-B3E3-F5FDA92683C7 Q36971248-F1690B85-9BBF-498A-9A80-C8D4748AD80F Q37060780-2814BB11-C07F-402D-9AFB-5297FFE45931 Q37076037-EA15762D-F241-4F11-AD30-1B4C37F793A4 Q37090184-B797E25D-B363-425A-A3F0-E8CF35223F5D Q37310131-6A982A59-E283-4639-A75B-C30362569393 Q37357727-72BFF3D5-96C1-4A5C-9039-790B2E8FBDEA Q37428179-8B128CEE-D4E9-4D8C-BDB3-14C9E06C8402 Q37434802-6B1DE8A6-52B4-4FBF-9C59-7FDEE388D4C4 Q37595816-3FEDAE9E-5AD2-4347-8868-597E39B7BE63 Q38700512-96DE758E-B445-4491-9FA0-DBBAF1AF2B21 Q38820418-FA8C420C-E2E4-4D87-A209-05E8B4B5AB11 Q38903367-47141FD7-C39A-412D-A782-95106CB52EA2 Q38918147-6E728DE7-4B27-4122-AE81-6E7CE0F6EEB7 Q39006153-AA8C2B6D-4B4A-442A-B961-EE9AC6C64E6F Q39147645-1C07BC2F-097B-4FCA-8B58-4DD46ED0B828 Q39267584-C34C8E2A-3EAA-4959-93E5-CEC6432BB762 Q39313594-3FAA1AD7-E1E4-49E1-884A-D03ED7A68C1F Q41068541-9DA7F3CB-B3FE-4E5E-87C0-672FE5EF6448 Q41674747-1EDFA0ED-76F6-480D-95CE-146F0F0E660E Q42616677-4B912038-A07D-4E60-A7B1-1E67437300B0 Q45061812-DBF692F1-29A0-4D03-8FF3-C67164BB9424 Q47107145-17C3C890-2E89-467A-822E-AD3CE2540DCC Q47172271-3704A831-88B4-4F14-9A90-7E17B9976113 Q47340121-1C6E567C-65A5-4CF7-89AE-84304494A43B

P2860

Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis.

http://www.wikidata.org/entity/Q35338937

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Flavin-containing monooxygenas ...... es-associated atherosclerosis.

@ast

Flavin-containing monooxygenas ...... es-associated atherosclerosis.

@en

type

label

Flavin-containing monooxygenas ...... es-associated atherosclerosis.

@ast

Flavin-containing monooxygenas ...... es-associated atherosclerosis.

@en

prefLabel

Flavin-containing monooxygenas ...... es-associated atherosclerosis.

@ast

Flavin-containing monooxygenas ...... es-associated atherosclerosis.

@en

P1433

Q35338937-375D1AF9-9D5B-4DE1-B89E-842BD011BACD

P1476

Q35338937-5CCA2269-C725-4BBF-AA57-0E74347DDE7B

P2093

Q35338937-371D134E-BB03-4EF6-A687-BA9235934510

Q35338937-4B8C50A7-BCA3-4B19-951C-DA77AD2F708B

Q35338937-573B6A7B-8452-47D8-9F6A-23623D3947B0

Q35338937-6EE52A4C-A1DB-44DD-A1CE-220791ECBD6D

Q35338937-75E64897-EBAD-4D30-8275-5E396809EEBF

Q35338937-93C670FB-2B1D-42AB-8B9F-11C262EAEC96

Q35338937-B8C10B29-C8E3-4E9B-A3BC-E7C10553EC2C

Q35338937-CE687575-DD7D-4723-91A2-5B1E1AE7A269

Q35338937-D74A8A7D-EC94-4D2C-ABAD-15AEC940E53D

Q35338937-E3B85FF7-AE2E-4AF0-93CB-1EE1FCD4C909

P2860

Q35338937-010AF428-DB20-4E10-891C-5F670B11D5EA

Q35338937-0E508F89-D515-459F-8358-7427122C20B5

Q35338937-102C6EDF-D8DA-466A-A906-720FA24AC564

Q35338937-19406091-4446-42D4-9372-12431EE75340

Q35338937-1983900A-2D43-457B-9545-617349F3D9E9

Q35338937-1C5DAC6C-9566-42BD-A0FE-0A519F3B4614

Q35338937-1FC38C1A-2CAD-4CF1-89DD-C2C26EEBC2F2

Q35338937-207E164B-1281-4D69-AEC8-5BF8312A170B

Q35338937-23F8B51A-2D13-4D40-8E0C-190AE85A977D

Q35338937-26B22846-EEE0-4FAB-A716-31EF5EF6925F

P2888

Q35338937-035E3D1D-7FD8-4548-A8E4-A1780E737C46

P304

Q35338937-1233FD71-AE4A-4C80-B317-29B9BE9DBDAE

P31

Q35338937-65AE5FFF-F3AD-4A6D-91FB-AAD8E75172B6

P356

Q35338937-860EF339-0DAC-4F32-8C14-9B7D3B1C18A8

P407

Q35338937-844E5D50-8CB2-4CA9-B7F8-1E7D6B6D9960

P478

Q35338937-40D4C08E-397A-4594-8A56-25ECCEE6FA3D

P50

Q35338937-51AC793A-259A-4820-8EA1-3D6AF4C77D9A

P577

Q35338937-469E59E4-635E-48F1-80AB-BC5EA858EF2A

P5875

Q35338937-3BCFCE29-EB23-4915-B20E-26083AC85CD0

P6179

Q35338937-2FA894AD-04A3-48FD-9A32-01F5AEBA5FFF

P698

Q35338937-29FAE59D-C2E2-4078-B3EA-80746291958A

P921

Q35338937-A210E8F6-9FBD-4CDA-A652-BFCA123EDED1

Q35338937-B77CBA58-833B-458D-AB84-E2234371645E

P932

Q35338937-E0FF6868-C98E-43B7-883D-0B942D365153

P356

P1433

Nature Communications

P1476

Flavin-containing monooxygenas ...... es-associated atherosclerosis.

@en

P2093

Alisha V Ling

http://www.w3.org/2001/XMLSchema#string

David Vicent

http://www.w3.org/2001/XMLSchema#string

Ji Miao

http://www.w3.org/2001/XMLSchema#string

Kevin J Croce

http://www.w3.org/2001/XMLSchema#string

Mark J Graham

http://www.w3.org/2001/XMLSchema#string

Mary E Gearing

http://www.w3.org/2001/XMLSchema#string

Morbid Obesity Study Group

http://www.w3.org/2001/XMLSchema#string

Praveen V Manthena

http://www.w3.org/2001/XMLSchema#string

Rosanne M Crooke

http://www.w3.org/2001/XMLSchema#string

Ryan M Esquejo

http://www.w3.org/2001/XMLSchema#string

P2860

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells

Statins in cardiometabolic disease: what makes pitavastatin different?

Does central obesity reflect "Cushing's disease of the omentum"?

Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation

Synchronous evolution of an odor biosynthesis pathway and behavioral response

FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge

P2888

P304

6498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS7498

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275824288

http://www.w3.org/2001/XMLSchema#string

P6179

1046591711

http://www.w3.org/2001/XMLSchema#string

P698

25849138

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4391288

http://www.w3.org/2001/XMLSchema#string